VALLEY COTTAGE, New York, October 5, 2017 /PRNewswire/ --
FMI has recently published an exclusive forecast report
(Logo: http://photos.prnewswire.com/prnh/20161020/430874LOGO )
Global Market Research Report Overview on Microbial Identification @ https://www.futuremarketinsights.com/reports/microbial-identification-market
North America to register steadfast adoption of microbial identification
A key discernment from the regional analysis delivered in the report exhibits the dominance of North America in the global microbial identification market. Considering how healthcare marketplaces in the US and Canada are robust, compared to other developed markets, and taking into account the rising contribution of North American academic institutes in developing research studies of medical microbiology, the adoption of microbial identification systems will be widespread in this region. Towards the end of forecast period, North America's microbial identification market will be worth around half a billion dollars, soaring robustly at a CAGR of 6.4%. Europe and Asia-Pacific excluding Japan (APEJ) will also be observed as lucrative markets for expansion of microbial identification.
Key Findings from the Report
In 2017, over two-fifth of revenues anticipated to be procured in the global microbial identification market will be accounted by sales of bacterial identification systems
Towards the end of forecast period, global sales of microbial remuneration systems will procure an estimated US$ 310 million in revenues
View Report Table of Contents, Figures, and Tables @ https://www.futuremarketinsights.com/reports/microbial-identification-market/toc
Throughout the forecast period, bacterial resistance identification systems will represent the fastest-selling product in the overall microbial identification market
Pharmaceuticals and biotechnology industry will remain the largest end-user of microbial identification by 2022
The end-use of microbial identification systems in water and environment sector will remain steady in 2017 and the following years
Between 2017 and 2022, the end-use of microbial identification across independent research laboratories in the world is anticipated to create an incremental opportunity of more than US$ 50 million
In 2017 and beyond, the use of microbial identification methods in blood banks will be subpar
Diagnostics remains to be a key application for microbial identification, revenues from which are anticipated to register above-average growth
A sample of this report is available upon request @ https://www.futuremarketinsights.com/reports/sample/rep-gb-5077
While detection of harmful microbes is viewed as a necessary measure for bolstering quality control in production of food items and drinks, the application of microbial identification in food & beverage testing will register a moderate CAGR in terms of revenues over the forecast period
On the basis of technologies, phenotypic microbial identification methods are anticipated to remain predominant in terms of adoption, albeit, genotypic technologies will register a marginally high CAGR during the assessment period
The report has further profiled companies that will be actively manufacturing microbial identification systems in the global market. Key players in the global microbial identification market include, Bruker Corporation, Danaher Corporation, Thermo Fisher Scientific, Inc., Shimadzu Corporation, Siemens Healthineers, QIAGEN N.V., Merck & Co Inc., bioMerieux S.A., Becton, Dickinson and Company, and Biolog, Inc. Many of these companies are expected to focus on developing microbial identification systems that befit the advancements in the field of medical microbiology. Specific requirements of microbiologist working in leading microbial identification projects will also influence the manufacturing techniques exercised by these companies.
Buy Microbial Identification Market Report
Future Market Insights (FMI) is a leading market intelligence and consulting firm. We deliver syndicated research reports, custom research reports and consulting services which are personalized in nature. FMI delivers a complete packaged solution, which combines current market intelligence, statistical anecdotes, technology inputs, valuable growth insights and an aerial view of the competitive framework and future market trends.
Contact Us 616 Corporate Way, Suite 2-9018, Valley Cottage, NY 10989, United States T: +1-347-918-3531 F: +1-845-579-5705 T (UK): +44(0)20-7692-8790 Sales: email@example.com
SOURCE Future Market Insights
Subscribe to our Free Newsletters!
Alström syndrome, a rare genetic disorder due to ALMS1 mutations, occurs in the first year of ...
Sodium zirconium cyclosilicate was approved by FDA recently to use as an oral suspension for ...
Encephalocele is a birth defect where a sac like protrusion of brain and covering membranes occurs ...View All